The platelet-to-high-density-lipoprotein-cholesterol ratio: a promising biomarker for predicting major adverse cardiovascular events in the Chinese community-based population
Front Cardiovasc Med. 2026 Oct 14;13:1868836. doi: 10.3389/fcvm.2026.1868836. eCollection 2026.ABSTRACTBACKGROUND: The platelet-to-high-density-lipoprotein-cholesterol ratio (PHR), a composite index integrating platelet count and HDL-C concentration, has recently attracted attention as a potential i

